enVVeno Medical Corp
NASDAQ:NVNO
enVVeno Medical Corp
NASDAQ:NVNO
Price:
11.5
USD
1.86%
Market Cap:
$7.6m
Balance Sheet
Balance Sheet Decomposition
enVVeno Medical Corp
enVVeno Medical Corp
Balance Sheet Decomposition is not available for
enVVeno Medical Corp
enVVeno Medical Corp
Balance Sheet
enVVeno Medical Corp
enVVeno Medical Corp
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
2
|
0
|
0
|
3
|
1
|
9
|
55
|
5
|
4
|
2
|
|
| Cash |
0
|
2
|
0
|
0
|
3
|
1
|
9
|
55
|
5
|
4
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
34
|
43
|
41
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
0
|
2
|
0
|
0
|
3
|
1
|
10
|
55
|
39
|
47
|
44
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
3
+79%
|
2
-38%
|
2
+24%
|
4
+61%
|
3
-4%
|
11
+207%
|
58
+447%
|
42
-28%
|
49
+17%
|
45
-8%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
1
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
5
|
2
|
8
|
2
|
2
|
3
|
2
|
2
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
1
|
1
|
1
|
|
| Total Liabilities |
4
N/A
|
5
+29%
|
2
-56%
|
8
+295%
|
2
-81%
|
2
+61%
|
3
+41%
|
3
-4%
|
3
-11%
|
2
-17%
|
3
+15%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
2
|
4
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
23
|
24
|
28
|
36
|
49
|
56
|
65
|
82
|
107
|
130
|
152
|
|
| Additional Paid In Capital |
21
|
21
|
24
|
24
|
51
|
57
|
72
|
136
|
145
|
176
|
194
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
2
+11%
|
0
+84%
|
6
-2 029%
|
2
N/A
|
1
-51%
|
7
+617%
|
54
+666%
|
39
-29%
|
46
+19%
|
42
-9%
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+79%
|
2
-38%
|
2
+24%
|
4
+61%
|
3
-4%
|
11
+207%
|
58
+447%
|
42
-28%
|
49
+17%
|
45
-8%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
